Synonyms: AZD-4721 | AZD4721 | compound 4 [WO2019055509A1] | RIST4721
Compound class:
Synthetic organic
Comment: Vimnerixin (AZD4721/RIST4721 ) is an orally bioavailable CXC chemokine receptor type 2 antagonist [1]. It has minimal activity on CXCR1, so has little effect on neutrophil activation.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[6-[(2R,3S)-3,4-dihydroxybutan-2-yl]oxy-2-[(4-fluorophenyl)methylsulfanyl]pyrimidin-4-yl]-3-methylazetidine-1-sulfonamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
12281 | vimnerixin |
Synonyms ![]() |
AZD-4721 | AZD4721 | compound 4 [WO2019055509A1] | RIST4721 |
Database Links ![]() |
|
CAS Registry No. | 1418112-77-2 (source: WHO INN record) |
GtoPdb PubChem SID | 472319222 |
PubChem CID | 71209600 |
Search Google for chemical match using the InChIKey | UCCNQCNIPRKLRP-CJNGLKHVSA-N |
Search Google for chemicals with the same backbone | UCCNQCNIPRKLRP |
Search PubMed clinical trials | vimnerixin |
Search PubMed titles | vimnerixin |
Search PubMed titles/abstracts | vimnerixin |
UniChem Compound Search for chemical match using the InChIKey | UCCNQCNIPRKLRP-CJNGLKHVSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UCCNQCNIPRKLRP-CJNGLKHVSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Vimnerixin (links to external site)
Cat. No. HY-145640 |